On 22 March 2018, The Lancet Neurology published online an interview with our project coordinator Professor Frederik Barkhof (pictured), Professor of Neuroradiology at the VU Medical Center Amsterdam and at the UCL Institute of Neurology. The article was titled “Frederik Barkhof: building bridges between disciplines”. We are glad to see that both EPAD and its sister project AMYPAD are mentioned.
The early academic journey of Professor Barkhof can be read on the journal website
Additionally to this article, we are delighted to announce that our project coordinator has been awarded the 2018 John Dystel Prize for his outstanding contribution to multiple sclerosis research in the understanding, treatment and prevention of multiple sclerosis. Professor Barkhof will receive his prize at the American Academy of Neurology’s 70th Annual Meeting in Los Angeles on 22 April 2018.
“I am super honoured”, he says, “to receive the John Dystel prize 2018 from the American Academy of Neurology and National MS Society. To be among those who have won is humbling”; Barkhof recalls the 1999 winner, late neurologist Ian McDonald, who was on the panel when Barkhof publically defended his thesis; “actually more of a show these days, still stressful, but also fun”, he says.
For more information about the AMYPAD project visit: www.amypad.eu
For more information about the EPAD project visit: http://ep-ad.org/
The AMYPAD project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115952. The Joint Undertaking receives support from the European Union’s Horizon2020 research and innovation programme and EFPIA.
The EPAD project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115736, resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.